Please login to the form below

Not currently logged in


This page shows the latest budesonide news and features for those working in and with pharma, biotech and healthcare.

Oxford study finds standard asthma medication improves recovery time in COVID-19 patients

Oxford study finds standard asthma medication improves recovery time in COVID-19 patients

Inhaled budesonide – a type of corticosteroid medication – is commonly used to treat asthma and chronic obstructive pulmonary disease. ... In addition, 32% of those receiving inhaled budesonide recovered within 14 days and remained well at 28 days

Latest news

More from news
Approximately 2 fully matching, plus 63 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2016 Deal Watch October 2016

    410. AstraZeneca (UK). Cilag J&J (US). Asset acquisition. Rhinocort (budesonide) nasal spray for rhinitis, global rights excluding US.

  • Deal Watch November 2015 Deal Watch November 2015

    So selling off the US rights for Entocort (budesonide), in the non-strategic field of mild to moderate Crohn's disease seems like small beer but the $380m paid by Perrigo ... 386. AstraZeneca. Perrigo. Acquisition - asset. Entocort (budesonide) marketed

  • Pharma deals in August 2015 Pharma deals in August 2015

    Baxalta aside, it has been a busy year for Shire which in February acquired the company Meritage bringing in a phase III ready oral budesonide solution for eosinophilic oesophagitis [an orphan

  • Pharma deals in July 2015 Pharma deals in July 2015

    Secondly, AZ sold Entocort (budesonide) global rights except the US to Tillotts, for $215m representing a sales multiple of 4. ... 250+. AstraZeneca / Tillotts. Product acquisition. Entocort (budesonide) marketed. 215. Occuleve / Allergan.

  • Medius Deal Watch table for February 2015 Medius Deal Watch table for February 2015

    Collaboration - develop and commercialise. 265. Meritage Pharma/ Shire. Phase 3-ready oral budesonide suspension (OBS) - eosinophilic esophagitis (EoE).

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...